Replies to post #602820 on NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

Not really. Announcing submission clarifies for good and all that the ball is out of NWBO’s hands and that they are on the clock for approval or rejection. No more of Linda’s black swans, no more BS, just an up or down and while yes the regulator could drag ass past the usual time frame, it is doubtful they will.

While some support will be provided for the SP which is good for financing, the price will still be cheap enough that shareholders can invest with greater confidence that this is really it, as it were.

Right now, by contrast, the full management risk is weighing things down.

[antihama]

I don't believe

Announcing submission/acceptance creates angst until approval

I see it as the company is making progress, and as a shareholder, am much more confident that I have a winner. I don't expect the application my biotech has submitted will be denied review, and I don't expect that once the application is accepted for review it won't be approved. I have those expectations because that's what my research tells me. If the application is denied review or upon review gets a Complete Response Letter, which are material events, I would expect it to be PR'd then. By PRing submission and/or acceptance of review there might be a little angst since nothing is ever a 100% but at least I'll have strongly positive expectations that it will be reviwed/approved and have that feel good feeling till that decision is made. There is no reason not to PR submission of application based on my experience of a biotech I owned and of recent examples of Vertex and Adaptimmune PRing start of rolling review submission a couple of months ago that was noted on this board.